This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, J. M.
Right arrow Articles by Cheng, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, J. M.
Right arrow Articles by Cheng, Q.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2002, p. 2435-2441, Vol. 46, No. 8
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.8.2435-2441.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Mutations in Cytochrome b Resulting in Atovaquone Resistance Are Associated with Loss of Fitness in Plasmodium falciparum

Jennifer M. Peters,1 Nanhua Chen,2 Michelle Gatton,1 Michael Korsinczky,2,3 Elizabeth V. Fowler,1 Sergio Manzetti,4 Allan Saul,5 and Qin Cheng2*

Malaria Laboratory, Infectious Diseases Unit, The Queensland Institute of Medical Research,1 Parasitology Department, Australian Army Malaria Institute,2 Centre for Molecular Biotechnology, Queensland University of Technology,4 Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia,3 Malaria Vaccine Development Unit, National Institutes of Health, Bethesda, Maryland5

Received 8 March 2002/ Returned for modification 3 April 2002/ Accepted 1 May 2002

Drug resistance in malarial parasites has become a major obstacle in the control of the disease. Strategies are urgently needed to control the development of resistance and to possibly reverse existing resistance. One key element required to reverse malaria drug resistance is for the parasites to "pay" a biological "cost" or suffer a loss of fitness when acquiring resistance to antimalarial drugs. Such a situation would be a disadvantage to the resistant parasites in the absence of drug pressure. We compared here the relative fitness of atovaquone-resistant Plasmodium falciparum K1 clones with single and double base mutations in their cytochrome b genes to their parent clones during erythrocytic stages in the absence of drug pressure. We found that the double amino acid mutation (M133I and G280D) is associated with a 5 to 9% loss of fitness and that the single amino acid change of M133I did not result in any detectable loss of fitness. Molecular modeling of the interaction of P. falciparum cytochrome b with ubiquinone led to the prediction that a loss of fitness of the malaria parasites would result from the G280D mutation due to its close proximity to the putative ubiquinone-binding site. This appears to have resulted in a weakening of the cytochrome b-ubiquinone complex, thereby causing the electron transport chain to become less efficient. Our results suggest that the prevalence of resistant parasites may decrease after the drug usage is discontinued.

* Corresponding author. Mailing address: Parasitology Department, Australian Army Malaria Institute, Gallipoli Barracks, Enoggera, Queensland 4051, Australia. Phone: 61-7-3332-4834. Fax: 61-7-3332-4800. E-mail: qin.cheng{at}defence.gov.au.

Antimicrobial Agents and Chemotherapy, August 2002, p. 2435-2441, Vol. 46, No. 8
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.8.2435-2441.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • TEMU, E. A., KIMANI, I., TUNO, N., KAWADA, H., MINJAS, J. N., TAKAGI, M. (2006). MONITORING CHLOROQUINE RESISTANCE USING PLASMODIUM FALCIPARUM PARASITES ISOLATED FROM WILD MOSQUITOES IN TANZANIA. Am J Trop Med Hyg 75: 1182-1187 [Abstract] [Full Text]  
  • Musset, L., Pradines, B., Parzy, D., Durand, R., Bigot, P., Le Bras, J. (2006). Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers. J Antimicrob Chemother 57: 110-115 [Abstract] [Full Text]  
  • Mather, M. W., Darrouzet, E., Valkova-Valchanova, M., Cooley, J. W., McIntosh, M. T., Daldal, F., Vaidya, A. B. (2005). Uncovering the Molecular Mode of Action of the Antimalarial Drug Atovaquone Using a Bacterial System. J. Biol. Chem. 280: 27458-27465 [Abstract] [Full Text]  
  • Kessl, J. J., Ha, K. H., Merritt, A. K., Lange, B. B., Hill, P., Meunier, B., Meshnick, S. R., Trumpower, B. L. (2005). Cytochrome b Mutations That Modify the Ubiquinol-binding Pocket of the Cytochrome bc1 Complex and Confer Anti-malarial Drug Resistance in Saccharomyces cerevisiae. J. Biol. Chem. 280: 17142-17148 [Abstract] [Full Text]  
  • YEUNG, S., PONGTAVORNPINYO, W., HASTINGS, I. M., MILLS, A. J., WHITE, N. J. (2004). ANTIMALARIAL DRUG RESISTANCE, ARTEMISININ-BASED COMBINATION THERAPY, AND THE CONTRIBUTION OF MODELING TO ELUCIDATING POLICY CHOICES. Am J Trop Med Hyg 71: 179-186 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»